SCHEMBL1354653

SCHEMBL1354653

O=C(O)c1cc(S(=O)(=O)n2ccc3ccccc32)ccc1Br

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.60
▸ L3MBTL1 Q9Y468 2/20 0.60
▸ MEN1 O00255 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ PKM P14618 1/20 0.60
▸ TDP1 Q9NUW8 2/20 0.59
▸ CTDSP1 Q9GZU7 1/20 0.59
▸ HTR6 P50406 6/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ LMNA P02545 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ TSHR P16473 1/20 0.58
▸ HSD17B10 Q99714 1/20 0.53
▸ FABP4 P15090 3/20 0.53
▸ HDAC3 O15379 2/20 0.51
▸ HDAC4 P56524 2/20 0.51
▸ HDAC1 Q13547 2/20 0.51
▸ HDAC7 Q8WUI4 2/20 0.51
▸ HDAC2 Q92769 2/20 0.51
▸ HDAC10 Q969S8 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1354690 0.80 HTT (0.60) HTTL3MBTL1MEN1KMT2APKM
SCHEMBL1357381 0.79 HTT (0.63) HTTL3MBTL1MEN1KMT2APKM
SCHEMBL27785348 0.79 HTR6 (0.58) HTTL3MBTL1MEN1KMT2APKM
SCHEMBL675296 0.77 HTT (0.65) HTTL3MBTL1MEN1KMT2APKM
SCHEMBL6357944 0.77 HTR6 (0.68) HTTL3MBTL1MEN1KMT2APKM
SCHEMBL4862697 0.76 HTT (1.00) HTTL3MBTL1MEN1KMT2APKM
SCHEMBL3972209 0.76 HTR6 (0.70) HTTL3MBTL1MEN1KMT2APKM
SCHEMBL29558135 0.75 HTR6 (1.00) HTTL3MBTL1MEN1KMT2APKM
SCHEMBL429849 0.75 HTR6 (1.00) HTTL3MBTL1MEN1KMT2APKM
SCHEMBL21968893 0.75 FABP4 (0.71) HTTL3MBTL1MEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318725-B2 Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2012-11-27 — — US disclosed
US-20110281849-A1 Aryl Indolyl Sulfonamide Compounds and Their Use as 5-HT6 Ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-11-17 — — US disclosed
WO-2010032257-A1 ARYL INDOLYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2010-03-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281849-A1 Aryl Indolyl Sulfonamide Compounds and Their Use as 5-HT6 Ligands HTR6, HTR1A, HTR2C HTT 157/4885L3MBTL1 4599/4885MEN1 2762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback